Effects of Valeriana officinalis (Valerian) on tension-type headache: A randomized, placebo-controlled, double-blind clinical trial

Azizi, Hossein and Shojaii, Asie and Hashem-Dabaghian, Fataneh and Noras, Mohammadreza and Boroumand, Amirreza and Ebadolahzadeh Haghani, Bita and Ghods, Roshanak (2020) Effects of Valeriana officinalis (Valerian) on tension-type headache: A randomized, placebo-controlled, double-blind clinical trial. Avicenna Journal of Phytomedicine, 10 (3). pp. 297-304.

[img] Text
AJP_Volume 10_Issue 3_Pages 297-304.pdf

Download (769kB)
Official URL: http://ajp.mums.ac.ir/article_14211.html

Abstract

Objective: Tension-type headache is the most frequent type of headache. Considering the effectiveness of Valeriana officinalis (Valerian) in treatment of some types of headache, the effect of valerian root was studied in patients with tension-type headache. Materials and Methods: The current study is a double-blind randomized clinical trial that was conducted in Shams Hospital of Mashhad University of Medical Sciences, Mashhad, Iran, from January to June 2018. We included 88 participants with tension-type headache and randomly assigned them to intervention and control group by block randomization in a 1:1 ratio. The intervention group received Sedamin® capsule (530 mg of valerian root extraction) while the placebo group received 500 mg of breadcrumbs both given as two capsules daily for a month -after dinner. The headache impact on activity of daily livings performance, headache disability, and headache severity were measured using questionnaires in baseline and one month after intervention in both groups. Results: The average age (±SD) of the participants was 34.9 (±8.7) years old. After one month, the impact of headache on daily livings performance, significantly reduced in intervention group (mean=51.2) versus the placebo (mean=57.0), (p<0.001). There was a significant reduction in disability in intervention group (mean=22.9) compared to the placebo (mean=27.4) (p<0.001) and the severity score showed significant reductions in intervention group (mean=3.5) versus the placebo group (mean=5.1) (p<0.001). Conclusion: The present trial showed that valerian capsule could reduce the headache impact on daily livings performance, disability and severity of tension-type headache.

Item Type: Article
Uncontrolled Keywords: Tension-type headache,Valeriana Officinalis,Persian Medicine,Clinical trial
Subjects: QT physiology
QU Biochemistry
QV pharmacology
QY Clinical Pathology
Divisions: Journals > Avicenna J Phytomedicine
Depositing User: ajp ajp
Date Deposited: 02 May 2020 07:39
Last Modified: 02 May 2020 07:39
URI: http://eprints.mums.ac.ir/id/eprint/19164

Actions (login required)

View Item View Item